Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Glutamate Carboxypeptidase II Inhibitor Screening Kit (Fluorometric)

Convenient assay for screening potential GCPII inhibitors
Catalog #: K440
$525.00

Product Details

Cat # +Size K440-100
Size 100 assays
Detection Method Fluorometric (Ex/Em= 535/587 nm)
Species Reactivity All
Applications Screening/characterizing Glutamate Carboxypeptidase II inhibitors
Features & Benefits •Includes Inhibitor Control (2-PMPA)
•Simple and reliable test to screen GCPII inhibitors/activators
•High-throughput compatible"
Kit Components •Human GCPII, 2-PMPA (10 mM)
•GCPII Assay Buffer
•GCPII Enzyme Mix
•PicoProbeTM (in DMSO)
•GCPII Developer
• GCPII Substrate
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

Glutamate Carboxypeptidase II [GCPII, EC 3.4.17.21; N-acetylated-alpha-linked acidic dipeptidase (NAALADase), prostate-specific membrane antigen (PSMA) or folate hydrolase (FOLH1)] is a multifunctional zinc-metallopeptidase. Within the last decade, GCPII has been studied as a promising pharmacological target for the treatment of various pathological disorders and diseases and tremendous efforts have been made in order to discover potent GCPII inhibitors. NAALADase, the brain isozyme, plays an important role in Glutamate biosynthesis and could be used for treating neuronal damage caused by excess glutamate in brain. For example, inhibition of GCPII has shown neuroprotective characteristics in animal models suffering several acute and chronic conditions (stroke, neuropathic and inflammatory pain, schizophrenia, depression or amyotrophic lateral sclerosis). In males, PSMA is overexpressed in patients suffering prostate cancer and thus, it is used as a diagnostic marker for this disease. BioVision’s Glutamate Carboxypeptidase II Inhibitor Screening Kit is an in vitro tool in order to screen potential human GCPII inhibitors. The provided substrate is transaminated in the presence of GCPII producing glutamate. The detection system is based on an enzymatic reaction in which a fluorogenic probe is reduced generating a stable signal. In the presence of 2-PMPA, a potent GCPII Inhibitor, the enzymatic activity is arrested, thus generating lower fluorometric signal. The assay kit is a simple plate-based format and provides a rapid and reliable test for high-throughput screening of GCPII inhibitors.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.